查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球生長因子市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按等級、按應用、按最終用戶、按地區
市場調查報告書
商品編碼
1394153

全球生長因子市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按等級、按應用、按最終用戶、按地區

Growth Factors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 391 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球生長因子市場規模預計將大幅擴大，從 2024 年的 22 億美元增至 2031 年底的 38 億美元。 製造商在推動這一增長、徹底改變皮膚再生、傷口癒合和治療應用方面發揮關鍵作用。

生長因子已成為皮膚再生和傷口癒合的基石。 研究人員正在努力開發超越單一生長因子解決方案的開創性產品，為市場的重大成長機會鋪路。 此外，亞太地區的快速成長以及專門生產良好生產規範 (GMP) 級產品的公司數量有限，為生長因子製造商提供了巨大的潛力。

細胞激素和生長因子在治療各種疾病方面的治療潛力預計將推動市場擴張。 自體免疫疾病和癌症盛行率的上升將進一步推動這一成長軌跡。

業界領先的進入者策略性地專注於新產品的批准、發布、研究合作、協議和夥伴關係。 這些策略旨在加強我們的產品組合併擴大我們的區域業務。 併購以及研發投資也是在各個治療和科學領域中利用成長因素的關鍵策略。

然而，生長因子市場面臨的挑戰主要是由於成本高和缺乏熟練的專業人員。 某些生長因子的成本阻礙了它們在實驗室中的採用。 合格專業人員的稀缺性以及獲得必要設備和配件的機會有限，進一步阻礙了市場的擴張。

本報告調查了全球生長因子市場，並提供了市場概述，以及按產品、等級、應用、最終用戶、區域劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第 3 章 2018-2031 年全球生長因子市場展望

  • 2018-2031 年全球成長因素市場前景（依產品、價值、數量劃分）
  • 2018-2031 年全球生長因子市場前景（依等級、價值、數量劃分）
  • 2018-2031 年全球生長因子市場前景（按應用、金額、數量劃分）
  • 2018-2031 年全球生長因子市場展望（依最終使用者、價值、數量）
  • 2018-2031 年全球生長因子市場前景（按地區、價值、數量劃分）

第 4 章北美生長因子市場展望，2018-2031

第 5 章歐洲生長因子市場展望，2018-2031

第 6 章亞太地區生長因子市場展望，2018-2031

第 7 章拉丁美洲生長因子市場展望，2018-2031

第 8 章中東與非洲生長因子市場展望，2018-2031 年

第九章競爭態勢

  • 依用途和等級劃分的熱圖
  • 按製造商和等級劃分的熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • Merck KGaA
    • General Electronics Company
    • F. Hoffmann-La Roche Ltd
    • Applied Biological Materials (abm), Inc
    • Abcam plc.
    • Cell Signaling Technology, Inc.
    • Sartorius CellGenix GmbH
    • Bio-Techne
    • Proteintech Group, Inc
    • Miltenyi Biotec
    • Creative Bioarray
    • Akron Biotech
    • Sino Biological Inc.
    • Repligen corporation
    • LEADGENE BIOMEDICAL, INC.
    • PeproTech In

第 10 章附錄

簡介目錄

The global growth factors market is poised for substantial expansion, with a remarkable surge in revenue from US $2.2 billion in 2024 to an estimated US $3.8 billion by the end of 2031. Manufacturers are playing a pivotal role in propelling this growth, revolutionizing skin regeneration, wound healing, and therapeutic applications.

Manufacturers Spearhead Market Growth

Growth factors have emerged as a cornerstone for skin regeneration and wound healing. Researchers are diligently working on pioneering products that extend beyond single growth factor solutions, paving the way for significant opportunities in the market. Additionally, the rapid growth of the Asia Pacific region and a limited number of companies specializing in Good Manufacturing Practice (GMP)-grade products create vast prospects for growth factor manufacturers.

Cytokine and Growth Factors Therapy Expands

The therapeutic potential of cytokine and growth factors in treating a range of disorders is expected to bolster market expansion. The rising prevalence of autoimmune diseases and cancer further fuels this growth trajectory.

Key Players Drive Expansion

Leading industry players are strategically focusing on new product approvals, launches, collaborations, agreements, and partnerships. These tactics are aimed at strengthening product portfolios and expanding regional presence. Mergers and acquisitions, along with investments in research and development, are also key strategies to harness growth factors in various therapeutic and scientific domains.

Challenges Ahead

However, the growth factors market faces its share of challenges, primarily stemming from high costs and a shortage of skilled professionals. The cost of certain growth factors hampers their adoption in research laboratories. A dearth of qualified experts and limited access to necessary equipment and accessories further impede market expansion.

Country-wise Insights

Why the U.S. is Thriving

The United States is witnessing a burgeoning demand for growth factors, driven by government initiatives supporting research activities and the growing importance of growth factors and cytokines in stem cell biology.

China's Emergence

China has become a prominent market for growth factors, particularly in the wake of the COVID-19 pandemic. As larger Chinese companies focus on developing growth factor-based medicines to combat the virus, the market for these products is rapidly expanding throughout China and East Asia.

Germany's Appeal

Germany stands out as a lucrative market for growth factors in Europe due to rising healthcare spending and the presence of robust manufacturing facilities. Major companies are expanding their product offerings through strategic acquisitions, such as Sartorius AG's acquisition of CellGenix in 2021 to bolster its cell and gene therapy product line.

Competitive Landscape

Key players in the growth factors market, including Thermo Fisher Scientific, Lonza Group AG, Merck KGaA, and others, are actively pursuing strategies to enhance their global presence. These strategies encompass new product releases, business expansion, approvals, partnerships, agreements, collaborations, and diversified distribution channels, including online sales.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • Lonza Group AG
  • Merck KGaA
  • General Electronics Company
  • F. Hoffmann-La Roche Ltd
  • Applied Biological Materials (abm), Inc
  • Abcam plc.
  • Cell Signaling Technology, Inc.
  • Meridian Bioscience Inc.
  • Sartorius CellGenix GmbH
  • Bio-Techne.
  • Proteintech Group, Inc.
  • Miltenyi Biotec
  • Creative Bioarray
  • Akron Biotech
  • Sino Biological Inc.
  • Repligen Corporation
  • LEADGENE BIOMEDICAL, INC.
  • PeproTech Inc.

Key Segments of the Growth Factors Industry Research:

By Product:

  • Transforming Growth Factors (TGF)

Activin

  • Bone Morphogenetic Proteins (BMPs)

TGF-beta Proteins

  • Epidermal Growth Factors (EGFs)
  • Platelet-Derived Growth Factors (PDGFs)
  • Fibroblast Growth Factors (FGFs)
  • Insulin-like Growth Factors (IGFs)
  • Vascular Endothelial Growth Factors (VEGFs)
  • Hepatocyte Growth Factors (HGFs)
  • Tumour Necrosis Factors (TNFs)
  • Interleukins
  • Others

By Grade:

  • GMP Grade
  • NON-GMP Grade

By Application:

  • Oncology Research
  • Hematology Research
  • Wound Healing Research
  • Dermatology Research
  • Cardiovascular Disease & Diabetes
  • Cell therapy and Ex vivo manufacturing
  • Others

By End User:

  • Pharmaceutical and Biotechnology Companies
  • Research Centres & Academic Institutes
  • CMO and CDMO

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Growth Factors Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Growth Factors Market Outlook, 2018 - 2031

  • 3.1. Global Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Transforming Growth Factors (TGF)
        • 3.1.1.1.1. Activin
        • 3.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 3.1.1.1.3. TGF-beta Proteins
      • 3.1.1.2. Epidermal Growth Factors (EGFs)
      • 3.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 3.1.1.4. Fibroblast Growth Factors (FGFs)
      • 3.1.1.5. Insulin-like Growth Factors (IGFs)
      • 3.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 3.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 3.1.1.8. Tumour Necrosis Factors (TNFs)
      • 3.1.1.9. Interleukins
      • 3.1.1.10. Others
  • 3.2. Global Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. GMP Grade
      • 3.2.1.2. NON-GMP Grade
  • 3.3. Global Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Oncology Research
      • 3.3.1.2. Hematology Research
      • 3.3.1.3. Wound Healing Research
      • 3.3.1.4. Dermatology Research
      • 3.3.1.5. Cardiovascular Disease & Diabetes
      • 3.3.1.6. Cell therapy and Ex vivo manufacturing
      • 3.3.1.7. Others
  • 3.4. Global Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Pharmaceutical and Biotechnology Companies
      • 3.4.1.2. Research Centres & Academic Institutes
      • 3.4.1.3. CMO and CDMO
  • 3.5. Global Growth Factors Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Growth Factors Market Outlook, 2018 - 2031

  • 4.1. North America Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Transforming Growth Factors (TGF)
        • 4.1.1.1.1. Activin
        • 4.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 4.1.1.1.3. TGF-beta Proteins
      • 4.1.1.2. Epidermal Growth Factors (EGFs)
      • 4.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 4.1.1.4. Fibroblast Growth Factors (FGFs)
      • 4.1.1.5. Insulin-like Growth Factors (IGFs)
      • 4.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 4.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 4.1.1.8. Tumour Necrosis Factors (TNFs)
      • 4.1.1.9. Interleukins
      • 4.1.1.10. Others
  • 4.2. North America Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. GMP Grade
      • 4.2.1.2. NON-GMP Grade
  • 4.3. North America Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oncology Research
      • 4.3.1.2. Hematology Research
      • 4.3.1.3. Wound Healing Research
      • 4.3.1.4. Dermatology Research
      • 4.3.1.5. Cardiovascular Disease & Diabetes
      • 4.3.1.6. Cell therapy and Ex vivo manufacturing
      • 4.3.1.7. Others
  • 4.4. North America Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Pharmaceutical and Biotechnology Companies
      • 4.4.1.2. Research Centres & Academic Institutes
      • 4.4.1.3. CMO and CDMO
  • 4.5. North America Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.2. U.S. Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.3. U.S. Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.4. U.S. Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.5. Canada Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.6. Canada Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.7. Canada Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.8. Canada Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Growth Factors Market Outlook, 2018 - 2031

  • 5.1. Europe Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Transforming Growth Factors (TGF)
        • 5.1.1.1.1. Activin
        • 5.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 5.1.1.1.3. TGF-beta Proteins
      • 5.1.1.2. Epidermal Growth Factors (EGFs)
      • 5.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 5.1.1.4. Fibroblast Growth Factors (FGFs)
      • 5.1.1.5. Insulin-like Growth Factors (IGFs)
      • 5.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 5.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 5.1.1.8. Tumour Necrosis Factors (TNFs)
      • 5.1.1.9. Interleukins
      • 5.1.1.10. Others
  • 5.2. Europe Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. GMP Grade
      • 5.2.1.2. NON-GMP Grade
  • 5.3. Europe Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Oncology Research
      • 5.3.1.2. Hematology Research
      • 5.3.1.3. Wound Healing Research
      • 5.3.1.4. Dermatology Research
      • 5.3.1.5. Cardiovascular Disease & Diabetes
      • 5.3.1.6. Cell therapy and Ex vivo manufacturing
      • 5.3.1.7. Others
  • 5.4. Europe Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Pharmaceutical and Biotechnology Companies
      • 5.4.1.2. Research Centres & Academic Institutes
      • 5.4.1.3. CMO and CDMO
  • 5.5. Europe Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.2. Germany Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.3. Germany Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.4. Germany Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.5. U.K. Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.6. U.K. Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.7. U.K. Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.8. U.K. Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.9. France Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.10. France Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.11. France Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.12. France Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.13. Italy Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.14. Italy Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.15. Italy Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.16. Italy Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.17. Turkey Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.18. Turkey Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.19. Turkey Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.20. Turkey Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.21. Russia Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.22. Russia Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.23. Russia Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.24. Russia Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.25. Rest of Europe Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.26. Rest of Europe Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.27. Rest of Europe Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.28. Rest of Europe Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Growth Factors Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Transforming Growth Factors (TGF)
        • 6.1.1.1.1. Activin
        • 6.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 6.1.1.1.3. TGF-beta Proteins
      • 6.1.1.2. Epidermal Growth Factors (EGFs)
      • 6.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 6.1.1.4. Fibroblast Growth Factors (FGFs)
      • 6.1.1.5. Insulin-like Growth Factors (IGFs)
      • 6.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 6.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 6.1.1.8. Tumour Necrosis Factors (TNFs)
      • 6.1.1.9. Interleukins
      • 6.1.1.10. Others
  • 6.2. Asia Pacific Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. GMP Grade
      • 6.2.1.2. NON-GMP Grade
  • 6.3. Asia Pacific Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Oncology Research
      • 6.3.1.2. Hematology Research
      • 6.3.1.3. Wound Healing Research
      • 6.3.1.4. Dermatology Research
      • 6.3.1.5. Cardiovascular Disease & Diabetes
      • 6.3.1.6. Cell therapy and Ex vivo manufacturing
      • 6.3.1.7. Others
  • 6.4. Asia Pacific Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Pharmaceutical and Biotechnology Companies
      • 6.4.1.2. Research Centres & Academic Institutes
      • 6.4.1.3. CMO and CDMO
  • 6.5. Asia Pacific Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.2. China Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.3. China Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.4. China Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.5. Japan Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.6. Japan Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.7. Japan Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.8. Japan Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.9. South Korea Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.10. South Korea Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.11. South Korea Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.12. South Korea Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.13. India Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.14. India Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.15. India Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.16. India Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.17. Southeast Asia Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.18. Southeast Asia Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.19. Southeast Asia Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.20. Southeast Asia Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Growth Factors Market Outlook, 2018 - 2031

  • 7.1. Latin America Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Transforming Growth Factors (TGF)
        • 7.1.1.1.1. Activin
        • 7.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 7.1.1.1.3. TGF-beta Proteins
      • 7.1.1.2. Epidermal Growth Factors (EGFs)
      • 7.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 7.1.1.4. Fibroblast Growth Factors (FGFs)
      • 7.1.1.5. Insulin-like Growth Factors (IGFs)
      • 7.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 7.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 7.1.1.8. Tumour Necrosis Factors (TNFs)
      • 7.1.1.9. Interleukins
      • 7.1.1.10. Others
  • 7.2. Latin America Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.1. GMP Grade
      • 7.2.1.2. NON-GMP Grade
  • 7.3. Latin America Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Oncology Research
      • 7.3.1.2. Hematology Research
      • 7.3.1.3. Wound Healing Research
      • 7.3.1.4. Dermatology Research
      • 7.3.1.5. Cardiovascular Disease & Diabetes
      • 7.3.1.6. Cell therapy and Ex vivo manufacturing
      • 7.3.1.7. Others
  • 7.4. Latin America Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Pharmaceutical and Biotechnology Companies
      • 7.4.1.2. Research Centres & Academic Institutes
      • 7.4.1.3. CMO and CDMO
  • 7.5. Latin America Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.2. Brazil Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.3. Brazil Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.4. Brazil Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.5. Mexico Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.6. Mexico Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.7. Mexico Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.8. Mexico Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.9. Argentina Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.10. Argentina Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.11. Argentina Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.12. Argentina Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Growth Factors Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Transforming Growth Factors (TGF)
        • 8.1.1.1.1. Activin
        • 8.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 8.1.1.1.3. TGF-beta Proteins
      • 8.1.1.2. Epidermal Growth Factors (EGFs)
      • 8.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 8.1.1.4. Fibroblast Growth Factors (FGFs)
      • 8.1.1.5. Insulin-like Growth Factors (IGFs)
      • 8.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 8.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 8.1.1.8. Tumour Necrosis Factors (TNFs)
      • 8.1.1.9. Interleukins
      • 8.1.1.10. Others
  • 8.2. Middle East & Africa Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. GMP Grade
      • 8.2.1.2. NON-GMP Grade
  • 8.3. Middle East & Africa Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Oncology Research
      • 8.3.1.2. Hematology Research
      • 8.3.1.3. Wound Healing Research
      • 8.3.1.4. Dermatology Research
      • 8.3.1.5. Cardiovascular Disease & Diabetes
      • 8.3.1.6. Cell therapy and Ex vivo manufacturing
      • 8.3.1.7. Others
  • 8.4. Middle East & Africa Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Pharmaceutical and Biotechnology Companies
      • 8.4.1.2. Research Centres & Academic Institutes
      • 8.4.1.3. CMO and CDMO
  • 8.5. Middle East & Africa Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.2. GCC Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.3. GCC Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.4. GCC Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.5. South Africa Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.6. South Africa Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.7. South Africa Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.8. South Africa Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.9. Egypt Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.10. Egypt Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.11. Egypt Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.12. Egypt Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.13. Nigeria Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.14. Nigeria Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.15. Nigeria Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.16. Nigeria Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. by Application vs by Grade Heatmap
  • 9.2. Manufacturer vs by Grade Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Thermo Fisher Scientific Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Lonza Group AG
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Merck KGaA
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. General Electronics Company
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. F. Hoffmann-La Roche Ltd
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Applied Biological Materials (abm), Inc
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Abcam plc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Cell Signaling Technology, Inc.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
      • 9.5.8.5. Meridian Bioscience Inc.
      • 9.5.8.6. Company Overview
      • 9.5.8.7. Product Portfolio
      • 9.5.8.8. Financial Overview
      • 9.5.8.9. Business Strategies and Development
    • 9.5.9. Sartorius CellGenix GmbH
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Bio-Techne
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Proteintech Group, Inc
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Miltenyi Biotec
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Creative Bioarray
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Akron Biotech
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. Sino Biological Inc.
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development
    • 9.5.16. Repligen corporation
      • 9.5.16.1. Company Overview
      • 9.5.16.2. Product Portfolio
      • 9.5.16.3. Financial Overview
      • 9.5.16.4. Business Strategies and Development
    • 9.5.17. LEADGENE BIOMEDICAL, INC.
      • 9.5.17.1. Company Overview
      • 9.5.17.2. Product Portfolio
      • 9.5.17.3. Financial Overview
      • 9.5.17.4. Business Strategies and Development
    • 9.5.18. PeproTech In
      • 9.5.18.1. Company Overview
      • 9.5.18.2. Product Portfolio
      • 9.5.18.3. Financial Overview
      • 9.5.18.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations